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TOWARDS AN UNDERSTANDING OF ALZHEIMER'S DISEASE II:
THE VULNERABILITY HYPOTHESIS: DO GLUCOCORTICOIDS INCREASE
CHOLINERGIC SUSCEPTIBILITY TO NEURAL TOXINS?
Heather A. Lang, Edmund C. Schweitzer and Wayne A. Dornan*,
Department of Psychology, IWU.

Alzheimer's disease

(AD)

is a neurodegenerative disorder, currently affecting over 4

million Americans, with 100,000 new cases reported each year.

AD is broadly characterized by a

global and progressive deterioration of memory, cognition, and personality.
clinical symptom of

AD

is memory loss.

The most evident

Studies in humans and rats report a significant

correlation between this memory loss and a decline in cholinergic markers, such as choline
acetyltransferase (ChAT) levels in the cerebral cortex and hippocampus. Therefore, one approach
towad developing an animal model of AD is to induce lesions in the hippocampus. This was
attempted in a number of studies, including one by Chrobak, Hanin, Schmechel, and Walsh

(I988),

in which lesioning of the hippocampus produced acetylcholine deficits, as measured by

lower ChAT levels, which in turn produced behavioral deficits. Recently, it has been found that

high concentrations of cortisol are linked to neuronal loss in AD. This postulate is a result of
accumulating evidence suggesting that hypercortisolemia and a decreased negative feedback

inhibition of cortisol secretion frequently accompany AD. In a recent study by Hortnagi, Berger,
Havelec, and Hornykiewicz (1993) they reported that, when injected bilaterally into the lateral

ventricles, the neurotoxin ethyicholine aziridinium (AF64A) induced specific reduction of ChAT
activity throughout the hippocampus.

In that same study, Hortnagl investigated the role of

giucocorticoids in the cholinergic degeneration brought about by bilateral intracerebroventricular

injections of AF64A (1 nmollventricle). They reported that chronic glucocorticoid administration
seven days before surgery potentiates the susceptibility of cholinergic neurons to AF64A-induced
deterioration.

Though Hortnagl and colleagues explored the neurophysiological effects of

glucocorticoid-potentiated AF64A toxicity, they did not explore the behavioral implications of
these

injections.

Therefore,

in

the

current

study

we

investigated

the

effects

of

intracerebroventricular injections of AF64A on spatial learning in male rats chronically treated
with glucocorticoids.

Four groups were compared: group one, AF64A plus sesame oil; group

two, AF64A plus corticosterone; group three, saline plus sesame oil; and group four, saline plus
corticosterone. These groups were subjected to a visual discrimination task involving both a fixed
and a floating platform in the Morris water maze. To assess the effects of the above injections,
several parameters were measured: path length, swim speed, session latency, and choice errors.
The results of this study will be presented at the conference.

